Vinay Prasad

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 61

Top Topics

Randomized Controlled Trial

Coronavirus Disease

Total Knee Arthroplasty

Top Venues

European journal of clinical investigation

Epidemiology and infection

Nature reviews. Clinical oncology

Medicine, health care, and philosophy

This page only lists publications with an associated author ORCID identifier.

Publications

Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiology and infection 152 (2024)
Sarah L Miller, Alyson Haslam, Vinay Prasad
Financial conflicts of interest among presenters, panellists and moderators at haematology and oncology FDA workshops. European journal of clinical investigation 54 (6) (2024)
Timothée Olivier, Alyson Haslam, Patricia Burke, Isabelle Boutron, Florian Naudet, John P A Ioannidis, Vinay Prasad
A novel framework to assess haematology and oncology registration trials: The THEOREMM project. European journal of clinical investigation (2024)
Mariana Barosa, John P A Ioannidis, Vinay Prasad
Evidence base for yearly respiratory virus vaccines: Current status and proposed improved strategies. European journal of clinical investigation (2024)
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiology and infection 152 (2024)
Vinay Prasad
CAR T cells in multiple myeloma: lessons learned. Nature reviews. Clinical oncology (2024)
Vinay Prasad
CAR T cells in multiple myeloma: lessons learned. Nature reviews. Clinical oncology 21 (8) (2024)
Christopher O Eden, Alyson Haslam, Vinay Prasad
Cancer Therapy, Gonadal Function, and Fertility Preservation: Narrative Review. JCO oncology practice (2024)
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
Pitfalls of Using Observational Studies in Harm-Benefit analyses of BNT161b2 vaccination of 5-11-Year-Olds. Epidemiology and infection (2024)
Vinay Prasad, Alyson Haslam
COVID-19 vaccines: history of the pandemic's great scientific success and flawed policy implementation. Monash bioethics review 42 (1) (2024)
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiology and infection 152 (2024)
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiology and infection 152 (2024)
Vinay Prasad, Alyson Haslam
COVID-19 vaccines: history of the pandemic's great scientific success and flawed policy implementation. Monash bioethics review (2024)
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiology and infection 152 (2024)
Vinay Prasad, Alyson Haslam
COVID-19 vaccines: history of the pandemic's great scientific success and flawed policy implementation. Monash bioethics review 42 (1) (2024)
Sarah L Miller, Alyson Haslam, Vinay Prasad
Financial conflicts of interest among presenters, panellists and moderators at haematology and oncology FDA workshops. European journal of clinical investigation (2024)
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiology and infection 152 (2024)
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiology and infection 152 (2024)
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiology and infection 152 (2024)
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiology and infection 152 (2024)
Mariana Barosa, Euzebiusz Jamrozik, Vinay Prasad
The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic. Medicine, health care, and philosophy 27 (1) (2023)
Tracy Beth Høeg, Shamez N Ladhani, Vinay Prasad
How methodological pitfalls have created widespread misunderstanding about long COVID. BMJ evidence-based medicine (2023)
Mariana Barosa, Euzebiusz Jamrozik, Vinay Prasad
The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic. Medicine, health care, and philosophy 27 (1) (2023)
Audrey A Tran, Vinay Prasad
Visualizing the randomized sham-controlled trial in orthopedic research: proposed steps to conducting a total knee arthroplasty randomized controlled trial. Journal of comparative effectiveness research (2023)
Audrey A Tran, Vinay Prasad
Visualizing the randomized sham-controlled trial in orthopedic research: proposed steps to conducting a total knee arthroplasty randomized controlled trial. Journal of comparative effectiveness research 12 (3) (2023)
Mariana Barosa, Euzebiusz Jamrozik, Vinay Prasad
The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic. Medicine, health care, and philosophy 27 (1) (2023)
Mariana Barosa, Euzebiusz Jamrozik, Vinay Prasad
The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic. Medicine, health care, and philosophy 27 (1) (2023)
Tracy Beth Høeg, Shamez N Ladhani, Vinay Prasad
Reliance on the highest-quality studies of Long Covid is appropriate and not evidence of bias. BMJ evidence-based medicine (2023)
Jordan E Tuia, Alyson Haslam, Vinay Prasad
Profile of the Oncology Physician Workforce and the Characteristics of Attrition. JCO oncology practice (2023)
Alyson Haslam, Timothée Olivier, Vinay Prasad
The definition of long COVID used in interventional studies. European journal of clinical investigation (2023)
Benjamin Knudsen, Vinay Prasad
COVID-19 vaccine induced myocarditis in young males: A systematic review. European journal of clinical investigation 53 (4) (2023)
Kerrington Powell, John Marquart, Timothée Olivier, Vinay Prasad
The role of surgery in metastatic cancer: the case for a pragmatic tumor-agnostic randomized trial. Future oncology (London, England) 18 (36) (2023)
Kerrington Powell, John Marquart, Timothée Olivier, Vinay Prasad
The role of surgery in metastatic cancer: the case for a pragmatic tumor-agnostic randomized trial. Future oncology (London, England) 18 (36) (2023)
Benjamin Knudsen, Vinay Prasad
COVID-19 vaccine induced myocarditis in young males: A systematic review. European journal of clinical investigation 53 (4) (2023)
Anushka Walia, Vinay Prasad
Current CML guidelines overemphasize second generation TKIs: revisiting the paradigm. Blood cancer journal 13 (1) (2023)
Kerrington Powell, John Marquart, Timothée Olivier, Vinay Prasad
The role of surgery in metastatic cancer: the case for a pragmatic tumor-agnostic randomized trial. Future oncology (London, England) 18 (36) (2023)
Audrey A Tran, Vinay Prasad
Visualizing the randomized sham-controlled trial in orthopedic research: proposed steps to conducting a total knee arthroplasty randomized controlled trial. Journal of comparative effectiveness research 12 (3) (2023)
Anushka Walia, Vinay Prasad
Current CML guidelines overemphasize second generation TKIs: revisiting the paradigm. Blood cancer journal 13 (1) (2023)
Anushka Walia, Jordan Tuia, Vinay Prasad
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed. Nature reviews. Clinical oncology (2023)
Anushka Walia, Vinay Prasad
Current CML guidelines overemphasize second generation TKIs: revisiting the paradigm. Blood cancer journal 13 (1) (2023)
Anushka Walia, Vinay Prasad
Current CML guidelines overemphasize second generation TKIs: revisiting the paradigm. Blood cancer journal 13 (1) (2023)
Kerrington Powell, John Marquart, Timothée Olivier, Vinay Prasad
The role of surgery in metastatic cancer: the case for a pragmatic tumor-agnostic randomized trial. Future oncology (London, England) (2023)
Mariana Barosa, Euzebiusz Jamrozik, Vinay Prasad
The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic. Medicine, health care, and philosophy (2023)
Benjamin Knudsen, Vinay Prasad
COVID-19 vaccine induced myocarditis in young males: A systematic review. European journal of clinical investigation (2022)
Benjamin Knudsen, Vinay Prasad
COVID-19 vaccine induced myocarditis in young males: A systematic review. European journal of clinical investigation (2022)
Timothée Olivier, Vinay Prasad
Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti-PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Benjamin Knudsen, Vinay Prasad
COVID-19 vaccine induced myocarditis in young males: A systematic review. European journal of clinical investigation (2022)
Kerrington Powell, Vinay Prasad
Multiplicity: When many analytic plans are applied or many redundant studies are run, false-positive results are ensured. European journal of clinical investigation 52 (8) (2022)
Kristin Wright, Daniel E Meyers, Timothy M Chisamore, Matthew D F McInnes, Sergio Sismondo, Bishal Gyawali, Vinay Prasad, Christopher M Booth
Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians? JCO oncology practice 18 (7) (2022)
Kerrington Powell, Vinay Prasad
Common misconceptions of randomized controlled trials in oncology. European journal of clinical investigation 52 (11) (2022)
Benjamin Knudsen, Vinay Prasad
COVID-19 vaccine induced myocarditis in young males: A systematic review. European journal of clinical investigation (2022)
Vinay Prasad
Reliable, cheap, fast and few: What is the best study for assessing medical practices? Randomized controlled trials or synthetic control arms? European journal of clinical investigation 51 (8) (2021)
Kerrington Powell, Vinay Prasad
Where are randomized trials necessary: Are smoking and parachutes good counterexamples? European journal of clinical investigation 52 (5) (2021)
Emerson Y Chen, Madeline M Cook, Christopher Deig, Asad Arastu, Vinay Prasad, Nima Nabavizadeh, Charles D Lopez, Adel Kardosh
Application of ASCO Value Framework to Treatment Advances in Hepatocellular Carcinoma. JCO oncology practice 17 (4) (2021)
Rahul Banerjee, Vinay Prasad
Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19. Nature reviews. Clinical oncology 18 (1) (2021)
Spencer Phillips Hey, Cory V Gerlach, Garrett S Dunlap, Vinay Prasad, Aaron S Kesselheim
The evidence landscape in precision medicine. Science translational medicine 12 (540) (2021)
Edward B Maldonado, Scott Parsons, Emerson Y Chen, Alyson Haslam, Vinay Prasad
Estimation of US patients with cancer who may respond to cytotoxic chemotherapy. Future science OA 6 (8) (2020)
Jennifer Gill, Vinay Prasad
A reality check of the accelerated approval of immune-checkpoint inhibitors. Nature reviews. Clinical oncology 16 (11) (2019)
Rachel J Cook, Jennifer Gill, Vinay Prasad
Registration studies - when should patients be deemed ineligible for aggressive therapy? Nature reviews. Clinical oncology 16 (6) (2019)
Jennifer Gill, Vinay Prasad
A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment. Research and practice in thrombosis and haemostasis 4 (1) (2019)
Jia Luo, Go Nishikawa, Vinay Prasad
A systematic review of head-to-head trials of approved monoclonal antibodies used in cancer: an overview of the clinical trials agenda. Journal of cancer research and clinical oncology 145 (9) (2019)
Vinay Prasad, Sham Mailankody
How should we assess the value of innovative drugs in oncology? Lessons from cost-effectiveness analyses. Blood 126 (15) (2015)